Biotech IPO Path Often Leads Toward Pharma Partnerships
This article was originally published in The Pink Sheet Daily
Executive Summary
Number of biotech IPOs declined to 17 in 2005 as more firms seek to partner with “big pharma,” according to BIO Venture Forum East panelists.